Patents by Inventor Chhabinath Mandal

Chhabinath Mandal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition useful for treating chronic myeloid leukemia
    Publication number: 20070161704
    Abstract: This invention relates to a pharmaceutical composition useful for treating chronic myeloid leukemia where Bcr-Abl kinase is constitutively expressed in animals and humans, and a treatment of chronic myeloid leukemia (CML) by a composition comprising an effective amount of analogs and/or salts of chlorogenic acid. The analogs are preferably sodium chlorogenate (Na-Chl) or potassium or ammonium salts, which were prepared from Chlorogenic acid or its analogs.
    Type: Application
    Filed: December 18, 2006
    Publication date: July 12, 2007
    Applicant: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    Inventors: Santu Bandyopadhyay, Bikas Pal, Samir Bhattacharyay, Swapan Mondal, Chhabinath Mandal, Aditya Konar, Keshab Roy, Tanusree Biswas, Gautam Bandyopadhyay
  • Pharmaceutical composition useful for treating chronic myeloid leukemia
    Publication number: 20050282892
    Abstract: This invention relates to a pharmaceutical composition useful for treating chronic myeloid leukemia where Bcr-Abl kinase is constitutively expressed in animals and humans, and a treatment of chronic myeloid leukemia (CML) by a composition comprising an effective amount of analogs and/or salts of chlorogenic acid. The analogs are preferably sodium chlorogenate (Na-Chl) or potassium or ammonium salts, which were prepared from Chlorogenic acid or its analogs.
    Type: Application
    Filed: July 6, 2005
    Publication date: December 22, 2005
    Inventors: Santu Bandyopadhyay, Bikas Pal, Samir Bhattacharyay, Swapan Mondal, Chhabinath Mandal, Aditya Konar, Keshab Roy, Tanusree Biswas, Gautam Bandyopadhyay
  • Pharmaceutical composition useful for treating chronic myeloid leukemia
    Publication number: 20040006138
    Abstract: The present invention relates to a pharmaceutical composition useful for treating chronic myeloid leukemia where Bcr-Abl kinase is constitutively expressed in animals and humans, said composition comprising an effective amount of analogs of chlorogenic acid such as neochlorogenic acid (5-O-caffeoyl quinic acid), cryptochlorogenic acid (4-O-Caffeoyl quinic acid), 3-O-(3′-methylcaffeoyl) quinic acid and 5-O-(Caffeoyl-4′-methyl) quinic acid and/or its salts such as sodium, potassium and ammonium together with pharmaceutically acceptable additives.
    Type: Application
    Filed: January 9, 2003
    Publication date: January 8, 2004
    Applicants: COUNCIL OF SCIENTIFIC, INDUSTRIAL RESEARCH
    Inventors: Santu Bandyopadhyay, Bikas Chandra Pal, Samir Bhattacharyay, Swapan Mondal, Chhabinath Mandal, Aditya Konar, Keshab Chandra Roy, Tanusree Biswas, Gautam Bandyopadhyay